The diagnostic delay in migraine disease

In a 2017 global study evaluating disease burden, headache disorders—most commonly identified as migraine—were the 2^nd most disabling disease.¹ Assuming a 7.4 billion population in 2016, the global prevalence of migraine is estimated to be approximately 14%², however, up to 45% of headache patients still seek care at headache centers around the